Haemonetics Corporation Share Price
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:00:02 16/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 121.34 USD | -1.30% |
|
+2.65% | +51.39% |
| 11-13 | Jefferies Initiates Coverage on Haemonetics With Buy Rating, $150 Price Target | MT |
| 11-13 | Haemonetics Corporation - Special Call |
| Market Cap | 5.6B 5.09B 4.7B 4.24B 8.01B 526B 8.29B 56.51B 22.39B 282B 21.01B 20.56B 894B | P/E 2027 * |
31.2x | P/E 2028 * | 23.5x |
|---|---|---|---|---|---|
| Enterprise Value | 6.57B 5.97B 5.51B 4.98B 9.4B 617B 9.73B 66.3B 26.27B 331B 24.64B 24.12B 1,048B | EV / Sales 2027 * |
4.55x | EV / Sales 2028 * | 3.91x |
| Free-Float |
98.72% | Yield 2027 * |
1.63% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
| HAE | Real-time | ||
| HAZ | Real-time | ||
| HAZ | Delayed | ||
| HAZ | Delayed | ||
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | -1.30% | ||
| 1 week | +2.65% | ||
| Current month | +1.41% | ||
| 1 month | +2.59% | ||
| 3 months | +34.42% | ||
| 6 months | +111.84% | ||
| Current year | +51.39% |
| 1 week | 116.68 | 126.08 | |
| 1 month | 115.49 | 132 | |
| Current year | 51 | 132 | |
| 1 year | 51 | 132 | |
| 3 years | 47.32 | 132 | |
| 5 years | 43.5 | 132 | |
| 10 years | 36.44 | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 15/05/2016 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 10/04/2022 |
Frank Chan
COO | Chief Operating Officer | 56 | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 31/12/2005 |
| Director/Board Member | 62 | 15/05/2016 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 17/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/10/26 | Tax | Executive/Senior Manager | -146 | 0.0003% | ||
| 24/07/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/07/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.30% | +2.65% | +63.27% | +36.00% | 5.6B | ||
| -0.99% | -2.77% | -17.37% | +7.17% | 188B | ||
| +0.02% | +0.09% | +6.86% | +37.39% | 126B | ||
| +0.35% | -4.61% | -13.72% | +6.58% | 118B | ||
| +1.18% | -4.80% | -42.14% | +3.55% | 92.48B | ||
| -0.58% | +3.23% | -2.21% | +81.27% | 68.51B | ||
| -0.72% | +0.57% | +13.35% | -7.91% | 59.39B | ||
| -0.51% | -0.85% | +4.73% | +50.15% | 55.48B | ||
| -2.26% | +4.42% | -3.31% | +45.02% | 49.62B | ||
| +1.27% | +1.50% | +1.21% | -0.19% | 35.17B | ||
| Average | -0.31% | +1.30% | +1.07% | +25.90% | 80B | |
| Weighted average by Cap. | -0.25% | +0.05% | -8.50% | +21.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.44B 1.31B 1.21B 1.09B 2.06B 135B 2.14B 14.57B 5.77B 72.71B 5.41B 5.3B 230B | 1.6B 1.45B 1.34B 1.21B 2.29B 150B 2.37B 16.14B 6.4B 80.58B 6B 5.87B 255B |
| Net income | 181M 165M 152M 137M 259M 17B 268M 1.83B 724M 9.13B 680M 665M 28.9B | 243M 221M 204M 185M 348M 22.86B 361M 2.46B 974M 12.27B 914M 894M 38.86B |
| Net Debt | 969M 881M 814M 735M 1.39B 91.01B 1.44B 9.78B 3.88B 48.84B 3.64B 3.56B 155B | 650M 590M 545M 492M 929M 60.99B 962M 6.56B 2.6B 32.73B 2.44B 2.39B 104B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | US$121.34 | -1.30% | 365,904 |
| 13/11/26 | US$122.94 | +0.19% | 439,696 |
| 12/11/26 | US$122.71 | +1.80% | 597,593 |
| 11/11/26 | US$120.54 | -1.49% | 390,243 |
| 10/11/26 | US$122.36 | +3.51% | 797,947 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
















